Drug paraphernalia including marijuana/cannabis and a methamphetamine pipe, following a police stop in Ferndale, CA, Author Ferndale Police Dept., Source https://kymkemp.com
(PD per California Public Records Act)
We continue our discussion of the risks and benefits of a drug-based psychiatric approach utilizing psychedelics to treat anxiety, depression, and post-traumatic stress disorder (PTSD).
Despite growing enthusiasm for the use of psychedelics, the evidence is far from in.
Lysergic acid diethylamide (LSD) – one of the most potent hallucinogens – was studied from the 1950s to 1970s in order to assess behavioral and personality changes, as well as relief from psychiatric symptoms [2A].
LSD was originally used in the treatment of anxiety, depression, addiction, and psychosomatic illness. Readers may recall that the US Army and CIA, also, experimented with LSD as a truth serum. But most early studies were not performed to today’s standards.
Across 11 randomized-controlled studies (involving a combined total of 567 patients) positive outcomes were observed, particularly with regard to alcoholism [2B].
In rare instances, however, psychedelics such as psilocybin and LSD can evoke a lasting psychotic reaction (more frequently in patients with a family history of psychosis) [3A]. Adequate screening of a patient’s vulnerability and prior psychotic episodes before the use of LSD is, therefore, emphasized. Continue reading